Hello, welcome to the 2026 virtual Annual M eeting of Entrada Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by using the question box on the bottom left of the annual meeting web portal. Good morning, everyone. My name is Dipal Doshi, and I am the Chief Executive Officer and Chairman of the 2026 virtual annual meeting of Entrada Therapeutics, Inc. The meeting is now called to order. I've asked Jared Cohen, General Counsel and Corporate Secretary of the company, to record the minutes. It is a pleasure to welcome our stockholders and visitors to the 2026 Annual Meeting of Stockholders of Entrada Therapeutics, Inc. This meeting is being held in accordance with the company's bylaws and Delaware law. We are conducting the annual meeting virtually instead of in person in order to leverage technology to facilitate the attendance and participation of our stockholders. We have stockholders attending via the web portal we provided. Our meeting today will consist of the formal business at hand, which is described in our proxy statement and notice of Internet availability of proxy materials, a copy of which was mailed on or about April 24th, 2026, to all of our stockholders of record as of the close of business on April 13th, 2026. During this portion of the meeting, all discussion will be limited to the official business at hand. Second, we will answer any questions that have to do with the official business at hand. Only validated stockholders may ask questions in the designated field on the web portal. Before proceeding to the formal business, I would like to introduce the following current members of the Board of Directors of the company who are present at the meeting via webcast. Kush M. Parmar, MD, PhD, Mary Thistle, Peter S. Kim, PhD, Bernhardt Zeiher, MD, Gina Chapman, and Maha Radhakrishnan, MD. Also present at the meeting via webcast are the following officers of the company. Nathan J. Dowden, President and Chief Operating Officer; Natarajan Sethuraman, PhD, President of Research and Development; and Kory Wentworth, Chief Financial Officer. I would also like to welcome representatives from our independent registered public accounting firm, Ernst & Young LLP, and representatives from our outside counsel, Goodwin Procter LLP. Broadridge Financial Solutions is acting as our tabulator. Let's proceed to the formal business of the meeting, notice of which was sent to all stockholders of record as of the close of business on April 13th, 2026. Stockholders of record as of the close of business on that date are entitled to vote at this meeting. A record of stockholders as of that date has been made available for inspection by any stockholder at the principal place of business of the company during normal business hours for the last 10 days immediately prior to the date of this meeting. If you have any questions on the rules of conduct for the meeting, you can find them posted at http://www.virtualshareholdermeeting.com/TRDA2026. Please note that only stockholders who have logged in using their 16-digit control number will be able to vote and ask questions at the meeting. If you have any questions, I would encourage you to please submit them now so that they will be in the queue to be answered. If any stockholder wishes to address the chairman during the formal part of this meeting, please do so by submitting your question in writing through the virtual meeting platform via the link provided. The Board of Directors has appointed Francis Byrd of The Carideo Group, Inc., to act as Inspector of Election for this annual meeting, and he will tabulate results of the voting. The Inspector of Election has signed the oath of his office, which will be filed with the minutes of this meeting. Mr. Byrd, do we have a quorum present? Mr. Doshi, of the 38,820,616 shares of common stock entitled to vote at the meeting, 33,190,234 shares are represented either virtually or by proxy. Therefore, a quorum is present. I declare that a quorum is present. We may now proceed to transact the business for which this meeting has been called. Let me briefly describe the voting procedures. Voting will be by proxy and online. If you have previously turned in your proxy and you do not intend to change your vote, it is not necessary that you complete another proxy or vote again via the web portal. Your vote will be counted. If you are eligible to vote and have not submitted your proxy, or if you want to change your vote, you may do so by clicking on the link provided through the virtual meeting platform. In order to allow stockholders to vote through this virtual meeting platform at any time during this meeting, I now declare the polls open for voting. It is now 9:34 A.M. on June 10th, 2026. Our first item of business is the election of directors. At this meeting, we'll be voting on two nominees for Class 2 directors to serve until the company's 2029 annual meeting of stockholders, as set forth in the proxy statement. In accordance with the bylaws, your directors have nominated Peter Kim and Bernhardt Zeiher to be elected to serve as Class 2 Directors. The company's bylaws require that a stockholder provide advance notice to the company of a stockholder's intent to nominate persons as directors. No such notice was received. Accordingly, I declare the nominations for directors closed. The Board of Directors unanimously recommends that stockholders vote in favor of this proposal. Mr. Cohen, have we received any questions concerning the proposal? We have not received any questions concerning the proposal. Anyone who is voting via the web portal, please vote now. The second item of business is the ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31st, 2026. The Audit Committee of the Board of Directors, which is comprised entirely of independent directors, appointed Ernst & Young LLP as the company's independent registered public accounting firm to audit the company's financial statements for the fiscal year ending December 31st, 2026. The Board of Directors approved the selection of Ernst & Young LLP and have asked the stockholders to ratify the selection. Stockholder ratification is not required by the company's bylaws. However, the board of directors is submitting this to the stockholders for ratification as a matter of good corporate governance. If the stockholders do not approve the selection of Ernst & Young LLP as the company's independent registered public accounting firm, the board of directors and the audit committee will reconsider the appointment. Mr. Cohen, have we received any questions concerning the proposal? We have received no questions. Anyone who is voting via the web portal, please vote now. The third item of business is the approval of Amendment Number 1 to the company's 2021 stock option and incentive plan. The board of directors unanimously recommends that stockholders vote in favor of this proposal. Mr. Cohen, have we received any questions concerning the proposal? We have received no questions. Anyone who is voting via the web portal, please vote now. The fourth item of business is the approval of A mendment Number 1 to the company's 2021 employee stock purchase plan. The board of directors unanimously recommends that stockholders vote in favor of this proposal. Mr. Cohen, have we received any questions concerning the proposal? We have received no questions concerning the proposal. Anyone who is voting via the web portal, please vote now. Anyone who has not yet voted and desires to do so, please do so now through the virtual meeting platform. The inspector of elections will not accept proxies or votes or any changes or revocations submitted after the closing of the polls. It is now 9:37 A.M. on June 10, 2026, and the polls for each matter to be voted on at this meeting are now closed. No additional proxies or votes and no changes or revocations will be accepted. Inspector of Elections, please report on the results of the voting. With regard to Proposal 1, a plurality of votes properly cast have been voted in favor of the election of the persons nominated. With regard to Proposal 2, the majority of the votes cast for and against the proposal have been voted in favor of the ratification of Ernst & Young LLP as the company's independent registered accounting firm for the fiscal year ending December 31, 2026. With regard to Proposal 3, a majority of the votes properly cast for and against the proposal have been voted in favor of the approval of the Amendment Number 1 to the company's 2021 Stock Option and Incentive Plan. With regard to Proposal 4, a majority of the votes properly cast for and against the proposal have been voted in favor of the approval of the Amendment Number 1 to the company's 2021 Employee Stock Purchase Plan. Thank you, Mr. Byrd. I declare that all of the proposals presented at the meeting have been approved or ratified by the stockholders. The final results of voting, including proxies and votes recorded during this meeting, will be set forth in the report of the Inspector of Elections and will be included in the minutes of the meeting. The final results will also be included in our reports filed with the SEC. There being no other matters for consideration at this meeting, I hereby adjourn this meeting. That concludes our meeting today. You may now disconnect.